Stella S Daskalopoulou1, Alexandra B Cooke2, Yessica-Haydee Gomez2, Andrew F Mutter2, Andreas Filippaios2, Ertirea T Mesfum2, Christos S Mantzoros3. 1. Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USADivision of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA stella.daskalopoulou@mcgill.ca. 2. Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 3. Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USADivision of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Irisin, a recently discovered myokine, has been shown to induce browning of white adipose tissue, enhancing energy expenditure and mediating some of the beneficial effects of exercise. We aimed to estimate the time frame of changes in irisin levels after acute exercise and the effect of different exercise workloads and intensities on circulating irisin levels immediately post-exercise. METHODS: In a pilot study, four healthy subjects (22.5±1.7 years) underwentmaximal workload exercise (maximal oxygen consumption, VO2 max) and blood was drawn at prespecified intervals to define the time frame of pre- and post-exercise irisin changes over a 24-h period. In the main study, 35 healthy, non-smoking (23.0±3.3 years) men and women (n=20/15) underwent three exercise protocols ≥48-h apart, in random order: i) maximal workload (VO2 max); ii) relative workload (70% of VO2 max/10 min); and iii) absolute workload (75 W/10 min). Blood was drawn immediately pre-exercise and 3 min post-exercise. RESULTS: In the pilot study, irisin levels increased by 35% 3 min post-exercise, then dropped and remained relatively constant. In the main study, irisin levels post-exercise were significantly higher than those of pre-exercise after all workloads (all, P<0.001). Post-to-pre-exercise differences in irisin levels were significantly different between workloads (P=0.001), with the greatest increase by 34% following maximal workload (P=0.004 vs relative and absolute). CONCLUSIONS:Circulating irisin levels were acutely elevated in response to exercise, with a greater increase after maximal workload. These findings suggest that irisin release could be a function of muscle energy demand. Future studies need to determine the underlying mechanisms of irisin release and explore irisin's therapeutic potential.
RCT Entities:
BACKGROUND:Irisin, a recently discovered myokine, has been shown to induce browning of white adipose tissue, enhancing energy expenditure and mediating some of the beneficial effects of exercise. We aimed to estimate the time frame of changes in irisin levels after acute exercise and the effect of different exercise workloads and intensities on circulating irisin levels immediately post-exercise. METHODS: In a pilot study, four healthy subjects (22.5±1.7 years) underwent maximal workload exercise (maximal oxygen consumption, VO2 max) and blood was drawn at prespecified intervals to define the time frame of pre- and post-exercise irisin changes over a 24-h period. In the main study, 35 healthy, non-smoking (23.0±3.3 years) men and women (n=20/15) underwent three exercise protocols ≥48-h apart, in random order: i) maximal workload (VO2 max); ii) relative workload (70% of VO2 max/10 min); and iii) absolute workload (75 W/10 min). Blood was drawn immediately pre-exercise and 3 min post-exercise. RESULTS: In the pilot study, irisin levels increased by 35% 3 min post-exercise, then dropped and remained relatively constant. In the main study, irisin levels post-exercise were significantly higher than those of pre-exercise after all workloads (all, P<0.001). Post-to-pre-exercise differences in irisin levels were significantly different between workloads (P=0.001), with the greatest increase by 34% following maximal workload (P=0.004 vs relative and absolute). CONCLUSIONS: Circulating irisin levels were acutely elevated in response to exercise, with a greater increase after maximal workload. These findings suggest that irisin release could be a function of muscle energy demand. Future studies need to determine the underlying mechanisms of irisin release and explore irisin's therapeutic potential.
Authors: Mark P Jedrychowski; Christiane D Wrann; Joao A Paulo; Kaitlyn K Gerber; John Szpyt; Matthew M Robinson; K Sreekumaran Nair; Steven P Gygi; Bruce M Spiegelman Journal: Cell Metab Date: 2015-08-13 Impact factor: 27.287
Authors: Paweł Jóźków; Dawid Koźlenia; Katarzyna Zawadzka; Marek Konefał; Paweł Chmura; Katarzyna Młynarska; Michał Kosowski; Marek Mędraś; Jan Chmura; Piotr Ponikowski; Jacek Daroszewski Journal: J Physiol Sci Date: 2018-05-14 Impact factor: 2.781
Authors: Suman Srinivasa; Caroline Suresh; Jay Mottla; Sulaiman R Hamarneh; Javier E Irazoqui; Walter Frontera; Martin Torriani; Takara Stanley; Hideo Makimura Journal: Growth Horm IGF Res Date: 2015-12-17 Impact factor: 2.372
Authors: S Buscemi; D Corleo; S Vasto; C Buscemi; M F Massenti; D Nuzzo; G Lucisano; A M Barile; G Rosafio; V Maniaci; C Giordano Journal: Int J Obes (Lond) Date: 2017-10-13 Impact factor: 5.095